Miltenyi Bioindustry Cell And Gene Therapy CDMO Services

Miltenyi Biotec has been pioneering cell and gene therapy for over 30 years, driving the industry forward since 1989. This flyer highlights their extensive CDMO services, which cover every step of the cell therapy workflow—from concept to commercialization. With facilities in North America, Europe, and Asia Pacific, Miltenyi Biotec offers global expertise and seamless support for your therapeutic development needs.

Their automated and closed-cell therapy manufacturing processes are designed to improve flexibility, shorten timelines, and enhance process efficiency also including clinical manufacturing, process development and optimization, commercial manufacturing, and analytical methods development. They have successfully produced over 700 clinical cell therapy batches and 400 clinical lentiviral vector (LVV) batches, treating more than 6,000 patients annually with their technologies.

Miltenyi Biotec's two-tier pilot phase for LVV manufacturing ensures platform compatibility and high success rates, reducing the need for costly process development steps and accelerating project timelines. Their regulatory expertise across 55+ countries makes them a reliable partner for your cell and gene therapy projects.

To explore how Miltenyi Biotec can turn your vision into reality with their end-to-end solutions, access the full flyer.